Buy & Sell Adaptive Biotechnologies Corp (ADPT) – Adaptive Biotechnologies Corp Price Today
Aura AI Summary
Key Stats
- $3.10BMarket Cap
- HealthSector
- -14.35%3M Drawdown
- $2.95BEnterprise Value
- -Dividend Yield
- 56% Buy | 44% SellTrading Activity
- 33 daysTypical Hold Time
Adaptive Biotechnologies Corp (ADPT) is currently valued at a market capitalization of $3.10B, with an enterprise value of $2.95B. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $10.24 and a high of $20.46, highlighting its annual price range. Over the past three months, Adaptive Biotechnologies Corp has recorded a drawdown of -14.35%, reflecting recent price volatility. On average, investors hold Adaptive Biotechnologies Corp for approximately 33 days, indicating typical investor behavior on the platform.
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Most Recent News
New MAPP report predicts a tough product cycle and hybrid vehicle rise in US auto market through 2031.
John Murphy, a veteran Wall Street auto analyst, launched Murphy Automotive Partners and its flagship product MAPP™, which forecasts the US vehicle pipeline through 2031. The report highlights a historic low in new model introductions, leading to an ...

New report warns US auto market faces a 3-year new model drought, with hybrids rising and EVs stalling.
Veteran auto analyst John Murphy launched Murphy Automotive Partners and its MAPP report forecasting US new car releases through 2031. The report highlights a deep 3-year product drought in the US market, with average vehicle age hitting a record hig...

New Murphy Automotive Partners report warns of a tough product slump and brand survival risks in US auto industry.
Murphy Automotive Partners, led by veteran analyst John Murphy, launched MAPP™, a new research platform analyzing US auto product pipelines through 2031. The report highlights a severe short-term product development slump, a shift from pure electric ...
